Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 3/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.46 |
| ▸ | CA2 | P00918 | 6/20 | 0.46 |
| ▸ | CA5A | P35218 | 3/20 | 0.46 |
| ▸ | CA1 | P00915 | 5/20 | 0.43 |
| ▸ | CA12 | O43570 | 3/20 | 0.43 |
| ▸ | CA9 | Q16790 | 3/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | CA3 | P07451 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | CA6 | P23280 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA13 | Q8N1Q1 | 2/20 | 0.43 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2214769 | 0.95 | CYP19A1 (0.52) | HTTKMT2AGAAALDH1A1CYP19A1 | |
| SCHEMBL2055461 | 0.88 | ALDH1A1 (0.46) | HTTKMT2AGAAALDH1A1CYP19A1 | |
| SCHEMBL20248063 | 0.86 | KMT2A (0.42) | HTTKMT2AGAAALDH1A1CYP19A1 | |
| SCHEMBL2820707 | 0.86 | ACP1 (0.43) | HTTKMT2AGAAALDH1A1CYP19A1 | |
| SCHEMBL15122462 | 0.86 | KMT2A (0.42) | HTTKMT2AGAAALDH1A1CYP19A1 | |
| SCHEMBL23113418 | 0.82 | HTT (0.42) | HTTKMT2AGAAALDH1A1CYP19A1 | |
| SCHEMBL16829550 | 0.82 | PTGS1 (0.46) | HTTKMT2AGAAALDH1A1MEN1 | |
| SCHEMBL17593373 | 0.82 | ALDH1A1 (0.46) | HTTKMT2AGAAALDH1A1CA2 | |
| SCHEMBL2310139 | 0.82 | VCAM1 (0.65) | HTTKMT2AGAAALDH1A1CYP19A1 | |
| SCHEMBL4443081 | 0.80 | CYP19A1 (0.62) | HTTKMT2AGAAALDH1A1CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8067625-B2 | Fluorosurfactants | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-11-29 | — | — | US | disclosed |
| US-8067625-B2 | Fluorosurfactants | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-11-29 | — | — | US | disclosed |
| US-8049022-B2 | Fluorosurfactants | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-11-01 | — | — | US | disclosed |
| US-8049022-B2 | Fluorosurfactants | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2011-11-01 | — | — | US | disclosed |
| US-20100152081-A1 | Fluorosurfactants | MERCK PATENT GMBH (DE) | 2010-06-17 | — | — | US | disclosed |
| US-20100152081-A1 | Fluorosurfactants | MERCK PATENT GMBH (DE) | 2010-06-17 | — | — | US | disclosed |
| US-20090312432-A1 | FLUOROSURFACTANTS | MERCK PATENT GESELLSCHAFT (DE) | 2009-12-17 | — | — | US | disclosed |
| US-20090312432-A1 | FLUOROSURFACTANTS | MERCK PATENT GESELLSCHAFT (DE) | 2009-12-17 | — | — | US | disclosed |
| US-20090264525-A1 | FLUOROSURFACTANTS | MERCK PATENT GMBH (DE) | 2009-10-22 | — | — | US | disclosed |
| US-20090264525-A1 | FLUOROSURFACTANTS | MERCK PATENT GMBH (DE) | 2009-10-22 | — | — | US | disclosed |
| WO-2008003444-A1 | FLUOROSURFACANTS | MERCK PATENT GMBH (DE) | 2008-01-10 | — | — | WO | disclosed |
| US-4438245-A | FOR LIGHT SENSITIVE ELEMENTS | FUJI PHOTO FILM CO., LTD. (JP) | 1984-03-20 | — | — | US | disclosed |
| US-4318864-A | REACTING 1,3,5-BENZENETRISULFONYL CHLORIDE WITH AMINOBENZENESULFONIC ACID, P-TERTIARY BUTYLPHENYL ESTER | AMERICAN CYANAMID COMPANY (US) | 1982-03-09 | — | — | US | disclosed |
| US-4265908-A | s-Phenenyltris(sulfonylimino)tri-benzene mono- and di-sulfonic acids and salts complement inhibitors | AMERICAN CYANAMID COMPANY (US) | 1981-05-05 | — | — | US | disclosed |
| US-4265829-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1981-05-05 | — | — | US | disclosed |
| EP-0013079-A1 | Symm. phenyltris(sulfonylimino)tri-benzene sulfonic acids and salts, a method of inhibiting the complement system in a body fluid with such a compound, a method for the preparation of such compounds and a pharmaceutical composition comprising such a compound | AMERICAN CYANAMID COMPANY (US) | 1980-07-09 | — | — | EP | disclosed |
| US-4208346-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1980-06-17 | — | — | US | disclosed |
| US-4172089-A | COMPLEMENT INHIBITOR TRI- OR HEXA-PHENYL ESTER INTERMEDIATES | AMERICAN CYANAMID COMPANY (US) | 1979-10-23 | — | — | US | disclosed |
| US-4117003-A | COMPLEMENT INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1978-09-26 | — | — | US | disclosed |
| US-4042393-A | Silver halide emulsion containing two equivalent type coupler for use in photography | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) | 1977-08-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090312432-A1 | FLUOROSURFACTANTS | SGMS2, FASN, SGMS1 | HTT 3902/4885KMT2A 2019/4885GAA 4096/4885 |
| US-20100152081-A1 | Fluorosurfactants | CBR3, FPR3, NOX3 | HTT 3411/4885KMT2A 2622/4885GAA 4217/4885 |
| US-20090264525-A1 | FLUOROSURFACTANTS | FASN, FFAR3, SGMS2 | HTT 3520/4885KMT2A 3037/4885GAA 4240/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.